MRNA-1273 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "MRNA-1273" in Japanese language version.

refsWebsite

Global rank Japanese rank

23web.archive.org

1^st place

22wikipedia.org

low place

12nih.gov

4^th place

24^th place

9reuters.com

49^th place

67^th place

7doi.org

2^nd place

6^th place

5cnbc.com

220^th place

1,047^th place

5nytimes.com

7^th place

63^rd place

5europa.eu

68^th place

425^th place

4fda.gov

447^th place

1,043^rd place

4cnn.com

28^th place

188^th place

3gov.uk

432^nd place

1,191^st place

3statnews.com

8,771^st place

low place

2canada.ca

1,712^th place

7,476^th place

2clinicaltrials.gov

5,225^th place

low place

2marketwatch.com

1,303^rd place

4,167^th place

2worldcat.org

5^th place

19^th place

2takeda.com

low place

2yahoo.com

38^th place

203^rd place

1idsociety.org

low place

1nihs.go.jp

low place

1,159^th place

1jiho.jp

low place

3,872^nd place

1mhlw.go.jp

1,656^th place

110^th place

1cdc.gov

218^th place

712^th place

1bioworld.com

low place

1businessinsider.com

140^th place

599^th place

1bloomberg.com

99^th place

542^nd place

1law.com

3,163^rd place

low place

1nejm.org

2,374^th place

2,486^th place

1biospace.com

low place

1fiercepharma.com

low place

1swissinfo.ch

1,485^th place

1,610^th place

1npr.org

92^nd place

562^nd place

1biopharmadive.com

low place

1rapidmicrobiology.com

low place

1wsj.com

79^th place

235^th place

1modernatx.com

low place

1nikkei.com

211^th place

13^th place

1cvdvaccine-us.com

low place

1fortune.com

433^rd place

1,942^nd place

1jakartaglobe.id

low place

1acs.org

1,248^th place

1,765^th place

1gov.sg

low place

1straitstimes.com

543^rd place

3,059^th place

1ft.com

210^th place

831^st place

1theguardian.com

12^th place

120^th place

1pm.gc.ca

low place

1financialpost.com

3,491^st place

low place

1pharmatimes.com

low place

1channelnewsasia.com

1,127^th place

5,408^th place

1swissmedic.ch

low place

1nhk.or.jp

145^th place

10^th place

1mixonline.jp

low place

4,576^th place

1latimes.com

22^nd place

197^th place

1usatoday.com

41^st place

199^th place

1nbcnews.com

137^th place

1,092^nd place

1forbes.com

54^th place

269^th place

acs.org

cen.acs.org

Mullin R (25 November 2020). “Pfizer, Moderna ready vaccine manufacturing networks”. Chemical & Engineering News (Washington, D.C.: American Chemical Society) 21 December 2020閲覧。

biopharmadive.com

“Moderna, in bid for transparency, discloses detailed plan of coronavirus vaccine trial”. BioPharma Dive. 16 November 2020時点のオリジナルよりアーカイブ。2020年9月18日閲覧。

biospace.com

Keown, Alex (2020年5月7日). “Moderna moves into Phase II testing of COVID-19 vaccine candidate”. BioSpace. 16 November 2020時点のオリジナルよりアーカイブ。2020年5月9日閲覧。

bioworld.com

Carey, Karen (26 February 2020). “Increasing number of biopharma drugs target COVID-19 as virus spreads”. BioWorld. 27 February 2020時点のオリジナルよりアーカイブ。1 March 2020閲覧。

bloomberg.com

“MIT Professor's Moderna Stake on the Brink of Topping $1 Billion”. Bloomberg News (18 May 2020). 18 May 2020閲覧。 “CEO Bancel, other Moderna executives have been selling shares”

businessinsider.com

markets.businessinsider.com

Everett, Gwen (27 February 2020). “These 5 drug developers have jumped this week on hopes they can provide a coronavirus treatment”. Markets Insider. 16 November 2020時点のオリジナルよりアーカイブ。1 March 2020閲覧。

canada.ca

covid-vaccine.canada.ca

“Regulatory Decision Summary - Moderna COVID-19 Vaccine”. カナダ保健省 (23 December 2020). 23 December 2020閲覧。
“Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)”. COVID-19 vaccines and treatments portal (23 December 2020). 23 December 2020閲覧。

cdc.gov

Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary et al. (December 2020). “The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020”. MMWR. Morbidity and Mortality Weekly Report 69 (5152). doi:10.15585/mmwr.mm695152e1.

channelnewsasia.com

“First shipment of Moderna's COVID-19 vaccine arrives in Singapore” (英語). CNA. 2021年2月17日閲覧。

clinicaltrials.gov

臨床試験番号 NCT04405076 研究名 "Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older" - ClinicalTrials.gov
臨床試験番号 NCT04470427 研究名 "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19" - ClinicalTrials.gov

cnbc.com

Lovelace Jr, Berkeley (19 December 2020). “FDA approves second Covid vaccine for emergency use as it clears Moderna's for U.S. distribution”. CNBC 19 December 2020閲覧。
Li, Yun (14 July 2020). “Dow futures jump more than 200 points after Moderna says its vaccine produces antibodies to coronavirus”. CNBC. 16 November 2020時点のオリジナルよりアーカイブ。15 July 2020閲覧。
Lovelace Jr, Berkeley; Higgins-Dunn, Noah (16 November 2020). “Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar”. CNBC 17 November 2020閲覧。
Tirrell, Meg (2021年1月14日). “Moderna looks to test Covid-19 booster shots a year after initial vaccination”. CNBC. 2021年1月18日閲覧。
Jr, Berkeley Lovelace (2021年6月10日). “Moderna asks FDA to clear Covid vaccine for adolescents 12 to 17” (英語). CNBC. 2021年8月11日閲覧。

cnn.com

“In quest for vaccine, US makes 'big bet' on company with unproven technology”. CNN (1 May 2020). 2020年5月13日時点のオリジナルよりアーカイブ。2020年5月2日閲覧。
Mascarenhas, Lauren (1 October 2020). “Moderna chief says Covid-19 vaccine could be widely available by late March”. CNN. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月2日閲覧。
Cohen, Elizabeth. “First large-scale US Covid-19 vaccine trial reaches target of 30,000 participants”. CNN. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月23日閲覧。
Cohen, Elizabeth (30 November 2020). “Moderna applies for FDA authorization for its Covid-19 vaccine”. CNN 4 December 2020閲覧。

cvdvaccine-us.com

“Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling”. Pfizer. 17 December 2020閲覧。

doi.org

Oliver, Sara E.; Gargano, Julia W.; Marin, Mona; Wallace, Megan; Curran, Kathryn G.; Chamberland, Mary et al. (December 2020). “The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020”. MMWR. Morbidity and Mortality Weekly Report 69 (5152). doi:10.15585/mmwr.mm695152e1.
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report, Lisa A. Jackson et al., New England Journal of Medicine 383 (Nov. 12, 2020), pp. 1920-1931, doi:10.1056/NEJMoa2022483.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Baden, Lindsey R. (30 December 2020). “Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine”. New England Journal of Medicine: NEJMoa2035389. doi:10.1056/NEJMoa2035389.
Dolgin E (November 2020). “COVID-19 vaccines poised for launch, but impact on pandemic unclear”. Nature Biotechnology. doi:10.1038/d41587-020-00022-y. PMID 33239758.
“Moderna loses key patent challenge”. Nature Biotechnology 38 (9): 1009. (September 2020). doi:10.1038/s41587-020-0674-1. PMID 32887970.

europa.eu

ec.europa.eu

"European Commission authorises second safe and effective vaccine against COVID-19". European Commission (Press release). 2021年1月6日閲覧。
“COVID-19 Vaccine Moderna”. Union Register of medicinal products. 14 January 2021閲覧。
“Coronavirus: Commission approves contract with Moderna to ensure access to a potential vaccine”. European Commission (25 November 2020). 4 December 2020閲覧。

ema.europa.eu

“COVID-19 Vaccine Moderna EPAR”. 欧州医薬品庁 (EMA). 20 January 2021閲覧。
"EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU" (Press release). European Medicines Agency. 6 January 2021. 2021年1月6日閲覧。

fda.gov

"FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. アメリカ食品医薬品局 (FDA) (Press release). 2020年12月18日閲覧。
Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). U.S. アメリカ食品医薬品局 (FDA) (Report). 18 December 2020. 2020年12月20日閲覧。 この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。
"Fact sheet for recipients and caregivers - Emergency Use Authorization (EUA) of the Moderna COVID-19 vaccine" (PDF). U.S. Food and Drug Administration (FDA) (Report). December 2020. 2020年12月31日閲覧。
“Vaccines and Related Biological Products Advisory Committee Meeting”. U.S. Food and Drug Administration (FDA) (December 17, 2020). 2021年2月20日閲覧。

fiercepharma.com

Blankenship, Kyle (2020年5月1日). “Moderna aims for a billion COVID-19 shots a year with Lonza manufacturing tie-up”. FiercePharma. 16 November 2020時点のオリジナルよりアーカイブ。2020年5月9日閲覧。

financialpost.com

Kuchler, Hannah (30 November 2020). “Canada could be among the first to clear Moderna's COVID-19 vaccine for use”. The Financial Post 4 December 2020閲覧。

forbes.com

Vardi, Nathan (29 June 2020). “Moderna's Mysterious Coronavirus Vaccine Delivery System”. Forbes 1 December 2020閲覧。.

fortune.com

“How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca”. Fortune. (5 December 2020). オリジナルの12 December 2020時点におけるアーカイブ。 5 December 2020閲覧。

ft.com

“Moderna pitches virus vaccine at about $32-$37 per course” (5 August 2020). 16 November 2020時点のオリジナルよりアーカイブ。29 July 2020閲覧。(要購読契約)

gov.sg

“Securing Singapore's access to COVID-19 vaccines”. www.gov.sg. Singapore Government (14 December 2020). 1 February 2021閲覧。

gov.uk

“Information for Healthcare Professionals on COVID-19 Vaccine Moderna”. 医薬品・医療製品規制庁 (MHRA) (8 January 2021). 8 January 2021閲覧。
“Conditions of Authorisation for COVID-19 Vaccine Moderna”. 医薬品・医療製品規制庁 (MHRA) (8 January 2021). 9 January 2021閲覧。
“Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator”. U.K. Government (8 January 2021). 8 January 2021閲覧。

idsociety.org

“Moderna COVID-19 Vaccine”. Dosing & Administration. Infectious Diseases Society of America (4 January 2021). 5 January 2021閲覧。

jakartaglobe.id

“Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss”. Jakarta Globe. (22 November 2020). オリジナルの7 December 2020時点におけるアーカイブ。 5 December 2020閲覧。

jiho.jp

nk.jiho.jp

“4成分の一般名決定、モデルナワクチンなど厚労省通知”. 日刊薬業. (2021年12月9日). https://nk.jiho.jp/article/167185 2021年12月21日閲覧。

latimes.com

Hiltzik, Michael (19 May 2020). “Column: Moderna's vaccine results boosted its share offering – and it's hardly a coincidence”. The Los Angeles Times. オリジナルの16 November 2020時点におけるアーカイブ。 19 May 2020閲覧。

law.com

Auth, Dorothy R.; Powell, Michael B. (14 September 2020). “Patent Issues Highlight Risks of Moderna's COVID-19 Vaccine”. New York Law Journal 1 December 2020閲覧。.

marketwatch.com

mhlw.go.jp

“武田／モデルナ社の新型コロナワクチンについて”. 厚生労働省. 2021年12月21日閲覧。

mixonline.jp

“厚労省　モデルナとアストラゼネカの新型コロナワクチンを特例承認　モデルナ製のみ公的接種の対象 | ニュース | ミクスOnline”. www.mixonline.jp. 2021年7月21日閲覧。

modernatx.com

investors.modernatx.com

“Moderna COVID-19 Vaccine Update” (PDF) (25 January 2021). 2021年2月20日閲覧。

nbcnews.com

“Moderna vaccine trial contractors fail to enroll enough people of color, prompting slowdown”. NBC News. Reuters. (6 October 2020) 17 November 2020閲覧。

nejm.org

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report, Lisa A. Jackson et al., New England Journal of Medicine 383 (Nov. 12, 2020), pp. 1920-1931, doi:10.1056/NEJMoa2022483.

nhk.or.jp

www3.nhk.or.jp

日本放送協会. “モデルナとアストラゼネカのワクチン正式承認厚労省”. NHKニュース. 2021年7月21日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Dolgin E (November 2020). “COVID-19 vaccines poised for launch, but impact on pandemic unclear”. Nature Biotechnology. doi:10.1038/d41587-020-00022-y. PMID 33239758.
“Moderna loses key patent challenge”. Nature Biotechnology 38 (9): 1009. (September 2020). doi:10.1038/s41587-020-0674-1. PMID 32887970.

nih.gov

“Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine”. US National Institutes of Health. (18 December 2020) 19 December 2020閲覧。
“NIH clinical trial of investigational vaccine for COVID-19 begins”. National Institutes of Health (NIH) (16 March 2020). 19 March 2020時点のオリジナルよりアーカイブ。18 March 2020閲覧。
“Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine”. National Institutes of Health (NIH) (15 November 2020). 2021年2月20日閲覧。

ncbi.nlm.nih.gov

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.

pmc.ncbi.nlm.nih.gov

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.
Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH (November 2020). “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report”. The New England Journal of Medicine 383 (20): 1920–1931. doi:10.1056/NEJMoa2022483. PMC 7377258. PMID 32663912.

dailymed.nlm.nih.gov

“Moderna COVID-19 Vaccine- cx-024414 injection, suspension”. DailyMed. 20 December 2020閲覧。

nihs.go.jp

jpdb.nihs.go.jp

“日本医薬品一般的名称（JAN）データベース検索結果”. 国立医薬品食品衛生研究所. 2021年12月21日閲覧。

nikkei.com

“ファイザーワクチン、日本でも通常冷凍保存に条件緩和”. 日本経済新聞 (2021年3月1日). 2021年7月15日閲覧。

npr.org

Palca, Joe (27 July 2020). “COVID-19 vaccine candidate heads to widespread testing in U.S.”. NPR. オリジナルの11 October 2020時点におけるアーカイブ。 27 July 2020閲覧。

nytimes.com

pharmatimes.com

“UK's MHRA starts rolling review of Moderna's COVID-19 vaccine”. PharmaTimes (28 October 2020). 4 December 2020閲覧。

pm.gc.ca

“New agreements to secure additional vaccine candidates for COVID-19”. Prime Minister's Office, Government of Canada (25 September 2020). 4 December 2020閲覧。

rapidmicrobiology.com

“Moderna Use Roche Antibody Test During Vaccine Trials”. rapidmicrobiology.com. 13 December 2020閲覧。

reuters.com

jp.reuters.com

Staff, Reuters「ファイザーのコロナワクチン、冷蔵庫で1カ月保管が可能＝米ＦＤＡ」『Reuters』2021年5月20日。2021年7月15日閲覧。
Staff, Reuters「武田、モデルナのワクチン5000万回分の追加供給で合意 22年初頭より」『Reuters』2021年7月20日。2021年7月21日閲覧。

statnews.com

Herper, Matthew; Garde, Damian (14 July 2020). “First data for Moderna Covid-19 vaccine show it spurs an immune response”. Stat (Boston Globe Media). オリジナルの14 July 2020時点におけるアーカイブ。 15 July 2020閲覧。
Branswell, Helen (19 May 2020). “Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccine”. Stat. 16 November 2020時点のオリジナルよりアーカイブ。19 May 2020閲覧。
FDA: Leave the door open to Covid-19 vaccination for pregnant and lactating health workers

straitstimes.com

Khalik, Salma (1 February 2021). “How Singapore picked its Covid-19 vaccines”. The Straits Times 1 February 2021閲覧。

swissinfo.ch

“Swiss factory rushes to prepare for Moderna Covid-19 vaccine”. SWI swissinfo.ch. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月7日閲覧。

swissmedic.ch

"Swissmedic grants authorisation for the COVID-19 vaccine from Moderna". Swissmedic (Press release). 12 January 2020. 2020年1月12日閲覧。

takeda.com

“「COVID-19ワクチンモデルナ筋注」の日本における接種対象年齢の拡大について”. www.takeda.com. 2021年8月11日閲覧。
“Moderna社の新型コロナウイルス感染症ワクチンの輸入および日本国内への供給に向けた製造販売承認申請について”. www.takeda.com. 2021年7月21日閲覧。

theguardian.com

“Donald Trump appears to admit Covid is 'running wild' in the US”. The Guardian. (22 November 2020). ISSN 0261-3077 22 November 2020閲覧. "Moderna told the Germany [sic] weekly Welt am Sonntag that it will charge governments between $25 and $37 per dose of its Covid vaccine candidate, depending on the amount ordered."

usatoday.com

Pregnant women haven't been included in promising COVID-19 vaccine trials

web.archive.org

Steenhuysen, Julie; Kelland, Kate (2020年1月24日). “With Wuhan virus genetic code in hand, scientists begin work on a vaccine”. Reuters. オリジナルの2020年1月25日時点におけるアーカイブ。 2020年1月26日閲覧。
Carey, Karen (26 February 2020). “Increasing number of biopharma drugs target COVID-19 as virus spreads”. BioWorld. 27 February 2020時点のオリジナルよりアーカイブ。1 March 2020閲覧。
Everett, Gwen (27 February 2020). “These 5 drug developers have jumped this week on hopes they can provide a coronavirus treatment”. Markets Insider. 16 November 2020時点のオリジナルよりアーカイブ。1 March 2020閲覧。
“NIH clinical trial of investigational vaccine for COVID-19 begins”. National Institutes of Health (NIH) (16 March 2020). 19 March 2020時点のオリジナルよりアーカイブ。18 March 2020閲覧。
“In quest for vaccine, US makes 'big bet' on company with unproven technology”. CNN (1 May 2020). 2020年5月13日時点のオリジナルよりアーカイブ。2020年5月2日閲覧。
Keown, Alex (2020年5月7日). “Moderna moves into Phase II testing of COVID-19 vaccine candidate”. BioSpace. 16 November 2020時点のオリジナルよりアーカイブ。2020年5月9日閲覧。
Blankenship, Kyle (2020年5月1日). “Moderna aims for a billion COVID-19 shots a year with Lonza manufacturing tie-up”. FiercePharma. 16 November 2020時点のオリジナルよりアーカイブ。2020年5月9日閲覧。
“Swiss factory rushes to prepare for Moderna Covid-19 vaccine”. SWI swissinfo.ch. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月7日閲覧。
Reuters Staff (2020年6月25日). “Moderna eyes third quarter for first doses of potential COVID-19 vaccine with Catalent deal”. Reuters. オリジナルの16 November 2020時点におけるアーカイブ。 6 November 2020閲覧。
Lee, Jaimy. “Moderna signs on for another COVID-19 vaccine manufacturing deal”. MarketWatch. 16 November 2020時点のオリジナルよりアーカイブ。9 July 2020閲覧。
Li, Yun (14 July 2020). “Dow futures jump more than 200 points after Moderna says its vaccine produces antibodies to coronavirus”. CNBC. 16 November 2020時点のオリジナルよりアーカイブ。15 July 2020閲覧。
Herper, Matthew; Garde, Damian (14 July 2020). “First data for Moderna Covid-19 vaccine show it spurs an immune response”. Stat (Boston Globe Media). オリジナルの14 July 2020時点におけるアーカイブ。 15 July 2020閲覧。
Palca, Joe (27 July 2020). “COVID-19 vaccine candidate heads to widespread testing in U.S.”. NPR. オリジナルの11 October 2020時点におけるアーカイブ。 27 July 2020閲覧。
“Moderna, in bid for transparency, discloses detailed plan of coronavirus vaccine trial”. BioPharma Dive. 16 November 2020時点のオリジナルよりアーカイブ。2020年9月18日閲覧。
Mascarenhas, Lauren (1 October 2020). “Moderna chief says Covid-19 vaccine could be widely available by late March”. CNN. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月2日閲覧。
Cohen, Elizabeth. “First large-scale US Covid-19 vaccine trial reaches target of 30,000 participants”. CNN. 16 November 2020時点のオリジナルよりアーカイブ。2020年10月23日閲覧。
“How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca”. Fortune. (5 December 2020). オリジナルの12 December 2020時点におけるアーカイブ。 5 December 2020閲覧。
“Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss”. Jakarta Globe. (22 November 2020). オリジナルの7 December 2020時点におけるアーカイブ。 5 December 2020閲覧。
“Trump says U.S. inks agreement with Moderna for 100 mln doses of COVID-19 vaccine candidate”. finance.yahoo.com (11 August 2020). 16 November 2020時点のオリジナルよりアーカイブ。2020年8月12日閲覧。
“Moderna pitches virus vaccine at about $32-$37 per course” (5 August 2020). 16 November 2020時点のオリジナルよりアーカイブ。29 July 2020閲覧。(要購読契約)
Hiltzik, Michael (19 May 2020). “Column: Moderna's vaccine results boosted its share offering – and it's hardly a coincidence”. The Los Angeles Times. オリジナルの16 November 2020時点におけるアーカイブ。 19 May 2020閲覧。
Branswell, Helen (19 May 2020). “Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccine”. Stat. 16 November 2020時点のオリジナルよりアーカイブ。19 May 2020閲覧。
Taylor, Marisa; Respaut, Robin (7 July 2020). “Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials”. Reuters. オリジナルの16 November 2020時点におけるアーカイブ。 10 July 2020閲覧。

wikipedia.org

en.wikipedia.org

“Regulatory Decision Summary - Moderna COVID-19 Vaccine”. カナダ保健省 (23 December 2020). 23 December 2020閲覧。
“COVID-19 Vaccine Moderna EPAR”. 欧州医薬品庁 (EMA). 20 January 2021閲覧。
“Information for Healthcare Professionals on COVID-19 Vaccine Moderna”. 医薬品・医療製品規制庁 (MHRA) (8 January 2021). 8 January 2021閲覧。
“Conditions of Authorisation for COVID-19 Vaccine Moderna”. 医薬品・医療製品規制庁 (MHRA) (8 January 2021). 9 January 2021閲覧。
"FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. アメリカ食品医薬品局 (FDA) (Press release). 2020年12月18日閲覧。
Moderna COVID-19 Vaccine Emergency Use Authorization (PDF). U.S. アメリカ食品医薬品局 (FDA) (Report). 18 December 2020. 2020年12月20日閲覧。 この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。
“MIT Professor's Moderna Stake on the Brink of Topping $1 Billion”. Bloomberg News (18 May 2020). 18 May 2020閲覧。 “CEO Bancel, other Moderna executives have been selling shares”
Auth, Dorothy R.; Powell, Michael B. (14 September 2020). “Patent Issues Highlight Risks of Moderna's COVID-19 Vaccine”. New York Law Journal 1 December 2020閲覧。.
"Fact sheet for recipients and caregivers - Emergency Use Authorization (EUA) of the Moderna COVID-19 vaccine" (PDF). U.S. Food and Drug Administration (FDA) (Report). December 2020. 2020年12月31日閲覧。
臨床試験番号 NCT04405076 研究名 "Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older" - ClinicalTrials.gov
Li, Yun (14 July 2020). “Dow futures jump more than 200 points after Moderna says its vaccine produces antibodies to coronavirus”. CNBC. 16 November 2020時点のオリジナルよりアーカイブ。15 July 2020閲覧。
Herper, Matthew; Garde, Damian (14 July 2020). “First data for Moderna Covid-19 vaccine show it spurs an immune response”. Stat (Boston Globe Media). オリジナルの14 July 2020時点におけるアーカイブ。 15 July 2020閲覧。
臨床試験番号 NCT04470427 研究名 "A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19" - ClinicalTrials.gov
“Is the Covid-19 Vaccine Effective Against New South African Variant?”. The New York Times (25 January 2021). 25 January 2021閲覧。
“Vaccines and Related Biological Products Advisory Committee Meeting”. U.S. Food and Drug Administration (FDA) (December 17, 2020). 2021年2月20日閲覧。
“Donald Trump appears to admit Covid is 'running wild' in the US”. The Guardian. (22 November 2020). ISSN 0261-3077 22 November 2020閲覧. "Moderna told the Germany [sic] weekly Welt am Sonntag that it will charge governments between $25 and $37 per dose of its Covid vaccine candidate, depending on the amount ordered."
Stevis-Gridneff M, Sanger-Katz M, Weiland N (18 December 2020). “A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines”. en:The New York Times 19 December 2020閲覧。
“Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine”. Reuters (3 February 2021). 3 February 2021閲覧。
Hiltzik, Michael (19 May 2020). “Column: Moderna's vaccine results boosted its share offering – and it's hardly a coincidence”. The Los Angeles Times. オリジナルの16 November 2020時点におけるアーカイブ。 19 May 2020閲覧。
Branswell, Helen (19 May 2020). “Vaccine experts say Moderna didn't produce data critical to assessing Covid-19 vaccine”. Stat. 16 November 2020時点のオリジナルよりアーカイブ。19 May 2020閲覧。
“Moderna vaccine trial contractors fail to enroll enough people of color, prompting slowdown”. NBC News. Reuters. (6 October 2020) 17 November 2020閲覧。
Vardi, Nathan (29 June 2020). “Moderna's Mysterious Coronavirus Vaccine Delivery System”. Forbes 1 December 2020閲覧。.

worldcat.org

search.worldcat.org

Rio, Giulia McDonnell Nieto del (2021年1月15日). “Covid-19: Over Two Million Around the World Have Died From the Virus”. The New York Times. ISSN 0362-4331 2021年1月18日閲覧。
“Donald Trump appears to admit Covid is 'running wild' in the US”. The Guardian. (22 November 2020). ISSN 0261-3077 22 November 2020閲覧. "Moderna told the Germany [sic] weekly Welt am Sonntag that it will charge governments between $25 and $37 per dose of its Covid vaccine candidate, depending on the amount ordered."

wsj.com

“Moderna Explores Whether Third Covid-19 Vaccine Dose Adds Extra Protection”. The Wall Street Journal. 2021年1月18日閲覧。

yahoo.com

finance.yahoo.com

“Trump says U.S. inks agreement with Moderna for 100 mln doses of COVID-19 vaccine candidate”. finance.yahoo.com (11 August 2020). 16 November 2020時点のオリジナルよりアーカイブ。2020年8月12日閲覧。

news.yahoo.com

“Israel authorises use of Moderna's COVID-19 vaccine” 5 January 2021閲覧。